DEBORA COLLOTTA; MASSIMO COLLINO. NLRP3 Inflammasome Signaling Platform as New Pharmacological Target for Metaflammation. Diabetes Research, [S. l.], v. 3, n. 1, p. e1-e3, 2016. DOI: 10.17140/DROJ-3-e008. Disponível em: http://openventio.us/index.php/DR/article/view/1635. Acesso em: 13 oct. 2026.